Danaher Corporation vs JPMorgan Equity Premium Income ETF — how do they compare? Danaher Corporation trades at $200.79 (market cap $140.88B), while JPMorgan Equity Premium Income ETF trades at $56.71. The key difference: Danaher Corporation pays a 0.8% dividend while JPMorgan Equity Premium Income ETF pays none, and Danaher Corporation is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| DHR | JEPI | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $242.05 | $59.88 |
52-Week Low | $161.91 | $55.29 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
JEPI trades at $56.76 with no price change, showing stability amid mixed technical signals. The ETF maintains a bullish technical outlook with strong moving average support, though oscillators suggest neutral momentum. Recent dividend payments of $0.39 and $0.45 demonstrate its income-focused strategy, while financial media highlights its 8%+ yield and covered call approach as key attractions for income investors.
JEPI's covered call strategy provides consistent income but limits upside potential during bull markets. The ETF faces competition from alternatives like SPYI and tax efficiency concerns, though its active management offers drawdown protection. Current technical strength supports near-term stability, but investors should weigh income benefits against capped returns in rising markets.
Trailing returns across standard periods
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →